Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.9066
-0.0128 (-1.39%)
At close: Aug 21, 2026, 4:00 PM EDT
0.911355
+0.0048 (0.52%)
After-hours: Aug 21, 2026, 7:31 PM EDT
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $251.22 million as of August 21, 2026. Its market cap has decreased by -69.63% in one year.
Market Cap
251.22M
Enterprise Value
294.86M
1-Year Change
-69.63%
Ranking
Category
Stock Price
$0.91
ChartMarket Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $251.22M, a decrease of -48.53%. That is a compound annual growth rate of -5.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 251.30M | -41.18% |
| Dec 31, 2025 | 427.20M | 3.06% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 444.74M |
| Alpha Teknova | 375.82M |
| Anika Therapeutics | 285.59M |
| Aurora Cannabis | 247.22M |
| Emergent BioSolutions | 247.14M |
| Organogenesis Holdings | 236.76M |
| Cardiol Therapeutics | 221.37M |
| SIGA Technologies | 213.39M |